Nucala Coupons & Prices

If you're comparing Nucala coupon options, here's what actually matters: Nucala (mepolizumab) is a brand-name biologic injection with no substitutable generic, so most people pay either through insurance, the manufacturer's copay program, or a cash discount — enter your ZIP above to see today's price at pharmacies near you.

What Is Nucala and How Does It Work?

Nucala (mepolizumab) is an interleukin-5 (IL-5) antagonist monoclonal antibody — a biologic that works by blocking IL-5, a protein that drives the production of eosinophils, a type of white blood cell involved in certain inflammatory conditions. It's given as a subcutaneous injection every 4 weeks, typically 100 mg for most approved uses or 300 mg for eosinophilic granulomatosis with polyangiitis (EGPA) and hypereosinophilic syndrome (HES).

Nucala is FDA-approved as an add-on maintenance treatment for severe eosinophilic asthma (age 6+), EGPA in adults, HES (age 12+, without another identifiable cause), chronic rhinosinusitis with nasal polyps in adults, and as an add-on maintenance treatment for COPD with an eosinophilic phenotype in adults. It is not a rescue treatment — it is not used to treat sudden asthma or COPD flare-ups or acute bronchospasm.

Nucala Coupon: Manufacturer Savings Card vs. Rx.com Cash Price

Nucala does not have a generic equivalent, so cost is one of the biggest questions patients ask. GSK, the manufacturer, offers an official Nucala copay savings program for eligible patients, but like most manufacturer copay cards, it's generally limited to people with commercial (private) insurance — terms, eligibility, and any caps can change, so check the manufacturer's site directly rather than relying on secondhand numbers. It typically is not usable if you're uninsured, on Medicare, Medicaid, or another government program, or if your insurance rejects the claim.

That's where an Rx.com cash coupon can help fill the gap: it works regardless of insurance status, including for uninsured patients or Medicare beneficiaries who don't qualify for the manufacturer card. GSK also offers separate patient assistance support for people who can't afford Nucala; ask your prescriber's office or GSK directly about eligibility. Enter your ZIP above to compare today's cash price at nearby pharmacies.

How Nucala Compares to Other Biologics

Nucala is one of several injectable biologics used for eosinophilic and allergic inflammatory conditions, and the right one depends on your specific diagnosis, age, and how your doctor wants to target the underlying inflammation. Other options in this space include Fasenra (benralizumab, also targets the IL-5 pathway), Xolair (omalizumab, targets IgE rather than IL-5), Dupixent (dupilumab, blocks IL-4/IL-13 signaling), Cinqair (reslizumab, another anti-IL-5 antibody), and Tezspire (tezepelumab, targets TSLP further upstream in the inflammatory pathway).

These drugs are not interchangeable and have different approved indications, age ranges, and dosing schedules. Your prescriber will choose based on your diagnosis (for example, whether you have nasal polyps, EGPA, or COPD alongside asthma) and how you've responded to prior treatments — this isn't a decision to make based on price alone.

Nucala Safety Information

Nucala's label carries warnings for hypersensitivity and anaphylaxis reactions, which can occur after any dose — including doses after the first — and sometimes appear on a delay. It also carries a warning about herpes zoster (shingles) infection risk, so your provider may recommend a vaccination before you start. Nucala should not be used to treat a sudden asthma or COPD flare-up, and if you're on oral or inhaled corticosteroids, they should be tapered gradually under medical supervision rather than stopped abruptly when starting Nucala.

Common side effects include headache, injection-site reactions, back pain, and fatigue. As with other biologics, talk to your prescriber before receiving any live vaccines while on Nucala. This is general information, not medical advice — always follow your prescriber's specific instructions and report any new or worsening symptoms.